BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 32792920)

  • 1. Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases.
    Guan Y; Han F
    Front Integr Neurosci; 2020; 14():37. PubMed ID: 32792920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
    Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
    Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease.
    Haque ME; Akther M; Jakaria M; Kim IS; Azam S; Choi DK
    Mov Disord; 2020 Jan; 35(1):20-33. PubMed ID: 31680318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammasome activation in neurodegenerative diseases.
    Ravichandran KA; Heneka MT
    Essays Biochem; 2021 Dec; 65(7):885-904. PubMed ID: 34846519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model.
    Gugliandolo A; Giacoppo S; Bramanti P; Mazzon E
    Inflammation; 2018 Feb; 41(1):93-103. PubMed ID: 28936769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Ageing Res Rev; 2020 Dec; 64():101192. PubMed ID: 33059089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
    Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases.
    Possemato E; La Barbera L; Nobili A; Krashia P; D'Amelio M
    Ageing Res Rev; 2023 Jun; 87():101907. PubMed ID: 36893920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
    Han QQ; Le W
    Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome.
    Shao QH; Zhang XL; Yang PF; Yuan YH; Chen NH
    Int Immunopharmacol; 2017 Aug; 49():155-160. PubMed ID: 28595078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies.
    Song L; Pei L; Yao S; Wu Y; Shang Y
    Front Cell Neurosci; 2017; 11():63. PubMed ID: 28337127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes.
    Gustin A; Kirchmeyer M; Koncina E; Felten P; Losciuto S; Heurtaux T; Tardivel A; Heuschling P; Dostert C
    PLoS One; 2015; 10(6):e0130624. PubMed ID: 26091541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.